The Nuclear Factor-κB RelA Transcription Factor Is Constitutively Activated in Human Pancreatic Adenocarcinoma Cells
暂无分享,去创建一个
[1] A. E. Rogers,et al. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. , 1997, The Journal of clinical investigation.
[2] C. Y. Wang,et al. Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras. , 1997, Science.
[3] Mike Rothe,et al. IκB Kinase-β: NF-κB Activation and Complex Formation with IκB Kinase-α and NIK , 1997 .
[4] Matthias Mann,et al. IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB Activation , 1997 .
[5] E. Zandi,et al. The IκB Kinase Complex (IKK) Contains Two Kinase Subunits, IKKα and IKKβ, Necessary for IκB Phosphorylation and NF-κB Activation , 1997, Cell.
[6] C. Der,et al. Oncogenic Ha-Ras-induced Signaling Activates NF-κB Transcriptional Activity, Which Is Required for Cellular Transformation* , 1997, The Journal of Biological Chemistry.
[7] David M. Rothwarf,et al. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB , 1997, Nature.
[8] D. Goeddel,et al. Identification and Characterization of an IκB Kinase , 1997, Cell.
[9] S. Leach,et al. Detection of mutated c-Ki-ras in the bile of patients with pancreatic cancer. , 1997, Anticancer research.
[10] T. Maniatis,et al. Activation of the IκBα Kinase Complex by MEKK1, a Kinase of the JNK Pathway , 1997, Cell.
[11] David Baltimore,et al. An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death , 1996, Science.
[12] Marty W. Mayo,et al. TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB , 1996, Science.
[13] Seamus J. Martin,et al. Suppression of TNF-α-Induced Apoptosis by NF-κB , 1996, Science.
[14] D. White,et al. Rel/NF-kappaB/IkappaB proteins and cancer. , 1996, Oncogene.
[15] J. Inoue,et al. MEK Kinase Is Involved in Tumor Necrosis Factor α-Induced NF-κB Activation and Degradation of IκB-α* , 1996, The Journal of Biological Chemistry.
[16] Scott E. Kern,et al. DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1 , 1996, Science.
[17] E M Schwarz,et al. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. , 1995, Genes & development.
[18] B. Aggarwal,et al. Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane) (*) , 1995, The Journal of Biological Chemistry.
[19] T. Maniatis,et al. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. , 1995, Genes & development.
[20] R. Bravo,et al. Overexpression of RelA in transgenic mouse thymocytes: specific increase in levels of the inhibitor protein I kappa B alpha , 1995, Molecular and cellular biology.
[21] G. Johnson,et al. Direct Interaction between Ras and the Kinase Domain of Mitogen-activated Protein Kinase Kinase Kinase (MEKK1) (*) , 1995, The Journal of Biological Chemistry.
[22] S. Gerstberger,et al. Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation , 1995, Science.
[23] M. Karin,et al. Phosphorylation of I kappa B alpha precedes but is not sufficient for its dissociation from NF-kappa B , 1995, Molecular and cellular biology.
[24] Jeffrey E. Lee,et al. Preoperative chemoradiation for adenocarcinoma of the pancreas: M.D. Anderson experience , 1995 .
[25] R. Kumar,et al. Inhibitory effect of curcumin on epidermal growth factor receptor kinase activity in A431 cells. , 1994, Biochimica et biophysica acta.
[26] G L Johnson,et al. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. , 1994, Science.
[27] N. Sonenberg,et al. Disruption of I kappa B alpha regulation by antisense RNA expression leads to malignant transformation. , 1994, Oncogene.
[28] I. Verma,et al. Enhanced I kappa B alpha degradation is responsible for constitutive NF-kappa B activity in mature murine B-cell lines , 1994, Molecular and cellular biology.
[29] I. Verma,et al. Autoregulation of I kappa B alpha activity. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[30] T. Tan,et al. Oncogene activation of HIV-LTR-driven expression via the NF-ϰB binding sites , 1993 .
[31] A. Baldwin,et al. Kappa B site-dependent induction of gene expression by diverse inducers of nuclear factor kappa B requires Raf-1. , 1993, The Journal of biological chemistry.
[32] U. Zabel,et al. Nuclear uptake control of NF‐kappa B by MAD‐3, an I kappa B protein present in the nucleus. , 1993, The EMBO journal.
[33] M. Nerenberg,et al. Ablation of transplanted HTLV-I tax-transformed tumors in mice by antisense inhibition of NF-kappa B. , 1992, Science.
[34] J. McPherson,et al. Related subunits of NF-kappa B map to two distinct loci associated with translocations in leukemia, NFKB1 and NFKB2. , 1992, Genomics.
[35] R. Chaganti,et al. B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-κB p50 , 1991, Cell.
[36] N. Andrews,et al. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. , 1991, Nucleic acids research.
[37] H. Ohno,et al. The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control , 1990, Cell.
[38] D. Baltimore,et al. I kappa B: a specific inhibitor of the NF-kappa B transcription factor. , 1988, Science.
[39] D. Shibata,et al. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes , 1988, Cell.
[40] H. Bose,,et al. Expression of the v-rel oncogene in reticuloendotheliosis virus-transformed fibroblasts. , 1988, Virology.
[41] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[42] H. Temin,et al. Activation of oncogenicity of the c-rel proto-oncogene , 1986, Molecular and cellular biology.
[43] P. Wingo,et al. Cancer statistics, 1997 , 1997, CA: a cancer journal for clinicians.
[44] Jeffrey E. Lee,et al. Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head* , 1996 .
[45] R. Hruban,et al. Molecular Biology and the Diagnosis and Treatment of Adenocarcinoma of the Pancreas , 1996 .
[46] A. Baldwin,et al. THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .
[47] M. Grilli,et al. NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. , 1993, International review of cytology.
[48] Hallin Pa,et al. MODELS OF PANCREATIC CANCER , 1993 .
[49] H. Bose,,et al. Transformation of avian lymphoid cells by reticuloendotheliosis virus. , 1988, Mutation research.
[50] G. Williams,et al. Application of a cellular test battery in the decision point approach to carcinogen identification. , 1988, Mutation research.
[51] D. Longnecker,et al. Experimental carcinogenesis in the pancreas. , 1984, International review of experimental pathology.